Citadel Advisors
DERM

Citadel Advisors’s Dermira, Inc. DERM Stock Holding History

Citadel Advisors’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-23,300
Closed -$353K – 10558
2019
Q4 		$353K Buy
23,300
+9,800
+73% +$84.6K ﹤0.01% 7338
2019
Q3 		$86K Buy
+13,500
New +$113K ﹤0.01% 8552
2019
Q2 		– Sell
-24,900
Closed -$337K – 10224
2019
Q1 		$337K Buy
24,900
+4,700
+23% +$39.2K ﹤0.01% 7447
2018
Q4 		$145K Buy
20,200
+6,400
+46% +$70K ﹤0.01% 8079
2018
Q3 		$150K Sell
13,800
-3,000
-18% -$30.3K ﹤0.01% 8399
2018
Q2 		$155K Sell
16,800
-35,300
-68% -$329K ﹤0.01% 8044
2018
Q1 		$416K Buy
52,100
+24,300
+87% +$529K ﹤0.01% 6220
2017
Q4 		$773K Buy
27,800
+7,100
+34% +$188K ﹤0.01% 5027
2017
Q3 		$559K Buy
+20,700
New +$542K ﹤0.01% 5161
2017
Q2 		– Sell
-6,200
Closed -$211K – 8347
2017
Q1 		$211K Buy
+6,200
New +$200K ﹤0.01% 6427
2016
Q3 		– Sell
-10,600
Closed -$310K – 8029
2016
Q2 		$310K Buy
+10,600
New +$293K ﹤0.01% 5164

Citadel Advisors's DERM Position: Q1 2020 in Review

Citadel Advisors sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 255,772 shares — an estimated $3.88M sold.

Citadel Advisors first reported a position in DERM in Q3 2015 and held it in 13 quarters. The position peaked at $13.3M in Q3 2017. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.

  • Citadel Advisors reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
  • Citadel Advisors sold 255,772 Dermira, Inc. shares in Q1 2020, an estimated $3.88M.
  • Citadel Advisors first reported a position in Dermira, Inc. in Q3 2015 and held it in 13 quarters.
  • Citadel Advisors's Dermira, Inc. position peaked at $13.3M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.

Based on Citadel Advisors's 13F filing for Q1 2020, filed 15 May 2020.